The European Biotech Venture Builder (EBVB) works towards democratising Drug Development. The EBVB aims to improve the current Status Quo of Drug Development by implementing their integrated business model, designed to decrease risk while delivering higher valuations and impact biotech products. They ensure that supported leaders focus on how to maximise their success in global markets from the very beginning, develop strategies to attract and deploy funds, and integrate different technical and capital-raising strategies to promote the venture’s success in the global marketplace.